▲ Peaking
Business
Silence Therapeutics aims at Takeda with new data in rare blood cancer
Silence Therapeutics reports a mid-stage victory for its gene-silencing drug divesiran in treating phlebotomy-dependent polycythemia vera.
1 trends tracked about this subject — the full history, oldest to newest below.
Silence Therapeutics reports a mid-stage victory for its gene-silencing drug divesiran in treating phlebotomy-dependent polycythemia vera.